This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
HIV and Managed Care: Where Are We Now?

HIV and Managed Care: Where Are We Now?

Format

Audio

Time to Complete

30 minutes

Released

March 31, 2017

Expires

March 30, 2018
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM
0.50 / CE for Pharmacists (0.05 CEUs)

Accredited Provider

CME: Albert Einstein College of Medicine
ACPE: University of Wisconsin-Madison Division of Pharmacy Professional Development

Commercial Supporter

Supported by an educational grant from Janssen Therapeutics

Producer



Produced by Haymarket Medical Education

Program Description

While the passage of the Affordable Care Act (ACA) has been integral in increasing the number of individuals with HIV who are engaged in treatment, not all patients are able to access appropriate care. Many patients with HIV are not linked with appropriate care and do not receive antiretroviral therapy; thus, they fail to achieve the viral suppression necessary to maintain long-term health and reduce HIV transmissibility. Low-income patients with HIV are particularly unlikely to receive care and life-saving HIV medications, despite the fact that they have significantly higher HIV-related mortality.

To be able to make informed decisions relevant to the provision of adequate healthcare to patients living with HIV/AIDS, and ensure that these individuals receive sustainable access to affordable medications, managed care health professionals require focused, in-depth education. In this audio discussion, Frank Romanelli, PharmD, and Richard Elion, MD, will discuss the current state of managed care in HIV treatment, and how managed care pharmacists, medical directors, and other providers can best serve patients with HIV in a rapidly changing health care landscape.

Intended Audience

Managed care medical and pharmacy directors (primary audience); primary care clinicians (secondary audience); and other physicians and pharmacists involved in HIV/AIDS care.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Summarize the ways in which the Affordable Care Act (ACA) and the expansion of Medicaid have impacted the care of patients living with HIV
  • Implement a team-based care approach to improve outcomes in patients with HIV/AIDS

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, the Albert Einstein College of Medicine, the University of Wisconsin-Madison, and Haymarket Medical Education (HME) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.

Faculty

Course Director
Barry S. Zingman, MD

Medical Director, AIDS Center
Clinical Director, Infectious Diseases, Moses Division
Montefiore Medical Center
Professor of Clinical Medicine, Albert Einstein College of Medicine
Bronx, NY

Dr. Zingman has nothing to disclose with regard to financial interests.

Faculty

Frank Romanelli, PharmD, MPH, AAHIVP
Professor & Associate Dean
University of Kentucky College of Pharmacy
Lexington, KY

Dr. Romanelli has nothing to disclose with regard to financial interests.

Richard A. Elion, MD
Associate Clinical Professor of Internal Medicine
George Washington University
Medical Director, CAPE
Private Practice
Washington, DC


Dr. Elion receives consulting fees from Gilead Sciences, Merck, and ViiV Healthcare. He is also on the speakers’ bureau for Gilead Sciences, Janssen Therapeutics, and Merck.

Accredited Provider Disclosure

The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.

The staff of the University of Wisconsin-Madison Interprofessional Continuing Education Partnership (ICEP) has nothing to disclose with regard to commercial support.

Publishing Staff Disclosures

Krista Sierra and Susan Basilico of Haymarket Medical Education have nothing to disclose with regard to commercial support.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Albert Einstein College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM . Physicians should only claim those credits commensurate with the extent of their participation in the activity.

Credit

0.50

Type

CE for Pharmacists

Accreditation Statement

In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement

A total of 0.50 hours (0.05 CEUs) of pharmacy CE credit will be provided for successful completion of this knowledge-based program. To receive CE credit, you must complete the program; complete the evaluation; and complete the post-test with a minimum score of 70%. Verification of completion will be provided to NABP within 60 days of completion of this program. No credit will be provided 60 days after this program expires.

Universal Program #0073-9999-17-035-H02-P

Disclosure of Unlabeled Use

This CME activity will not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, University of Wisconsin-Madison, Janssen Therapeutics, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact:
For CME – Millie Adighiuzor at 718-920-6674
For CPEcemail@pharmacy.wisc.edu

Instructions

To obtain credit, a score of 70% or better on the post-test is required. Please proceed until you have successfully completed this activity and completed the post-test and evaluation, and for CME credit only, that you have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For CPE credit, your credit will automatically be provided to NABP within 60 days of completing the activity.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue